Mitsubishi UFJ Trust & Banking Corp lessened its holdings in Davita Inc (NYSE:DVA) by 63.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 113,572 shares of the company’s stock after selling 194,539 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.07% of Davita worth $8,135,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of DVA. Atlas Capital Advisors LLC boosted its position in Davita by 247.9% in the 3rd quarter. Atlas Capital Advisors LLC now owns 2,592 shares of the company’s stock valued at $188,000 after buying an additional 1,847 shares during the period. Green Square Capital LLC acquired a new stake in shares of Davita in the 2nd quarter valued at $208,000. Seven Eight Capital LP acquired a new stake in shares of Davita in the 3rd quarter valued at $219,000. Private Advisor Group LLC acquired a new stake in shares of Davita in the 3rd quarter valued at $249,000. Finally, NumerixS Investment Technologies Inc raised its holdings in shares of Davita by 123.7% in the 2nd quarter. NumerixS Investment Technologies Inc now owns 3,600 shares of the company’s stock valued at $253,000 after purchasing an additional 1,991 shares in the last quarter. 85.76% of the stock is owned by institutional investors.
Shares of DVA opened at $61.82 on Friday. Davita Inc has a twelve month low of $58.68 and a twelve month high of $80.71. The firm has a market capitalization of $10.64 billion, a PE ratio of 18.62, a PEG ratio of 0.85 and a beta of 1.07. The company has a current ratio of 1.84, a quick ratio of 1.82 and a debt-to-equity ratio of 2.09.
Davita (NYSE:DVA) last announced its quarterly earnings results on Wednesday, November 7th. The company reported $0.56 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.89 by ($0.33). Davita had a return on equity of 13.87% and a net margin of 5.39%. The company had revenue of $2.85 billion for the quarter, compared to analyst estimates of $2.93 billion. During the same quarter in the prior year, the business earned $0.81 earnings per share. Davita’s revenue was up 3.0% compared to the same quarter last year. Equities analysts expect that Davita Inc will post 3.56 EPS for the current year.
A number of brokerages have recently weighed in on DVA. Zacks Investment Research lowered shares of Davita from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. Raymond James upgraded shares of Davita from a “market perform” rating to an “outperform” rating and set a $70.00 price objective on the stock in a report on Wednesday, November 28th. They noted that the move was a valuation call. ValuEngine lowered shares of Davita from a “buy” rating to a “hold” rating in a report on Wednesday, October 17th. JPMorgan Chase & Co. upgraded shares of Davita from an “underweight” rating to a “neutral” rating in a report on Thursday, September 13th. Finally, TheStreet lowered shares of Davita from a “b-” rating to a “c+” rating in a report on Thursday, November 8th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $80.16.
COPYRIGHT VIOLATION WARNING: This story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/12/07/mitsubishi-ufj-trust-banking-corp-sells-194539-shares-of-davita-inc-dva.html.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
See Also: Price to Earnings Ratio (PE), For Valuing Stocks
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.